Skip to main content

Table 1 Relationship between the expressions of VEGFR2 and VTN with clinicopathological features

From: VEGFR2 promotes tumorigenesis and metastasis in a pro-angiogenic-independent way in gastric cancer

Clinicopathologic features No. VEGFR2 expression VTN expression
High (No.) Low (No.) χ2 P value High (No.) Low (No.) χ2 P value
Gender   96 60    92 64   
 Men 110 65 45 0.944 0.331 62 48 1.051 0.305
 Women 46 31 15 30 16
Age (years)
 <65 90 53 37 0.631 0.427 51 39 0.468 0.494
 ≥65 66 43 23 41 25
Tumor size (cm)
 <5 101 58 43 2.047 0.153 55 46 2.418 0.12
 ≥5 55 38 17 37 18
Lauren type
 Intestinal type 91 55 36 0.111 0.739 53 38 0.048 0.826
 Diffuse type 65 41 24 39 26
Degree of differentiation
 Highly 46 28 18 0.012 0.912 26 20 0.162 0.687
 Moderately and Poorly 110 68 42 66 44
Depth of invasion
 T1, T2 61 28 33 10.348 <0.001** 27 34 8.961 <0.003**
 T3, T4 95 68 27 65 30
Lymphonodus metastasis
 N0, N1 50 22 28 9.563 <0.002** 21 29 8.763 <0.003**
 N2, N3 106 74 32 71 35
AJCC stage
 I, II 51 18 33 22.05 <0.001** 18 33 17.561 <0.001**
 III, IV 105 78 27    74 31   
  1. **indicates P<0.01